Using MRI to identify patients with sarcoidosis at risk for bad cardiac outcomes

heart disease
Credit: CC0 Public Domain

Researchers from the University of Minnesota Medical School found that patients with certain features on magnetic resonance imaging (MRI) of the heart are at much higher risk for cardiac sarcoidosis-related adverse outcomes. These patients may benefit from an implantable cardioverter defibrillator. Meanwhile, other features identified patients at very low risk who might not benefit from the device. These findings were published recently in JAMA Cardiology.

Cardiac sarcoidosis is a rare inflammatory heart disease that can result in rhythm disturbances and heart failure. Sarcoidosis is estimated to affect approximately 200,000 Americans.

"Late gadolinium enhancement on cardiovascular imaging is often used to diagnose cardiac sarcoidosis. Our research shows that not all patients with late gadolinium enhancement on cardiac MRI have the same risk of adverse outcomes, particularly ," said Chetan Shenoy, MBBS, MS, an associate professor of medicine at the University of Minnesota Medical School and the lead author of the study. "We believe our findings will help optimize the clinical care of patients with suspected cardiac sarcoidosis, and consequently, lead to better outcomes."

In this largest study yet of suspected cardiac sarcoidosis investigated by cardiac MRI, the researchers studied 504 patients. The MRI features were based on the research team's previously published study that described features of cardiac damage in the hearts of patients with cardiac sarcoidosis who had suddenly died or needed heart transplantation.

Researchers note that these findings should be replicated in other, more diverse cohorts. Whether clinical management guided by these cardiac MRI features improves outcomes in patients with suspected cardiac should be prospectively tested in a randomized trial.

More information: Pal Satyajit Singh Athwal et al, Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis, JAMA Cardiology (2022). DOI: 10.1001/jamacardio.2022.2981

Journal information: JAMA Cardiology
Citation: Using MRI to identify patients with sarcoidosis at risk for bad cardiac outcomes (2022, October 4) retrieved 26 February 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New research provides insights into sex differences in patients with suspected cardiac sarcoidosis


Feedback to editors